老年肺癌根治性放疗患者食管炎发生率较低
研究基于密歇根大学前瞻性数据库125例及密歇根放射肿瘤学质量联盟注册库691例接受根治性肺部放疗的患者,采用逻辑回归分析年龄与食管炎、肺炎的关系。结果显示年龄与食管炎发生率呈显著负相关(校正OR=0.93,95%CI分别为0.88-0.98和0.87-0.99),年龄与肺炎无显著关联。结论认为老年患者对根治性胸部放疗耐受良好,临床有指征时应提供该选择。
要点
- 年龄与食管炎发生率呈显著负相关,校正化疗使用后仍存在。
- 年龄与肺炎发生风险无显著关联。
- 老年患者可良好耐受根治性胸部放疗,临床有指征时应提供。
核心结论
- 年龄增长与食管炎发生率降低相关,校正化疗使用后仍存在,此为胸部肿瘤学新发现。
- 年龄与肺毒性无显著关联。
- 老年患者能良好耐受根治性胸部放疗,临床有指征时应提供该选择。
研究设计与样本
- 从密歇根大学前瞻性机构数据库识别125例接受根治性肺部放疗的患者。
- 在密歇根放射肿瘤学质量联盟注册库(独立全州前瞻性数据库)691例患者中验证分析。
- 采用逻辑回归模型评估年龄对食管炎≥2级或≥2级及肺炎≥3级或≥2级的影响,分别校正食管和肺剂量、化疗使用、吸烟状态和体能状态。
主要发现
- 密歇根大学队列中,多变量回归模型显示年龄与食管炎发生率在两个毒性级别均呈显著负相关,校正OR均为0.93,95%CI分别为0.88-0.98和0.87-0.99。
- 两个模型曲线下面积分别为0.747和0.721,显示拟合良好。
- 密歇根放射肿瘤学质量联盟队列中观察到相同关联。
- 年龄与肺炎无显著关联。
临床怎么用
- 作者结论认为老年患者能良好耐受根治性胸部放疗,临床有指征时应提供该选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Most patients with lung cancer are elderly and poorly represented in randomized clinical trials. They are often undertreated because of concerns about their ability to tolerate aggressive treatment. We tested the hypothesis that elderly patients undergoing definitive lung radiation might tolerate treatment differently than younger patients. METHODS: A total of 125 patients who underwent definitive lung radiotherapy were identified from a prospective institutional database (University of Michigan cohort). Logistic regression modeling was performed to assess the impact of age on esophagitis grade 2 or higher or grade 2 or higher and pneumonitis grade 3 or higher or grade 2 or higher, with adjustment for esophageal and lung dose, respectively, as well as for chemotherapy utilization, smoking status, and performance status. The analysis was validated in a large cohort of 691 patients from the Michigan Radiation Oncology Quality Consortium registry, an independent statewide prospective database. RESULTS: In the University of Michigan cohort, multivariable regression models revealed a significant inverse correlation between age and rate of esophagitis for both toxicity levels, (adjusted OR = 0.93 for both models and 95% confidence intervals of 0.88-0.98 and 0.87-0.99), with areas under the curve of 0.747 and 0.721, respectively, demonstrating good fit. This same association was noted in the Michigan Radiation Oncology Quality Consortium cohort. There was no significant association between age and pneumonitis. CONCLUSIONS: There is a lower incidence of esophagitis with increasing age even after adjustment for use of chemotherapy. This is a novel finding in thoracic oncology. No age dependence was noted for pulmonary toxicity. The elderly are able to tolerate definitive thoracic radiation well and should be offered this option when clinically warranted.
引用
- Soni PD, Boonstra PS, Schipper MJ, et al. Lower Incidence of Esophagitis in the Elderly Undergoing Definitive Radiation Therapy for Lung Cancer. J Thorac Oncol. 2017. PMID: 28161553. doi:10.1016/j.jtho.2016.11.2227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。